Insider Trading Alert - KEX, XEC And PRGO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 24, 2014, 153 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $614.00 to $8,867,579,754,879.72.

Highlighted Stocks Traded by Insiders:

Kirby (KEX) - FREE Research Report

Strahan Dorman Lynn who is President - Marine Systems, In at Kirby sold 4,000 shares at $101.38 on Feb. 24, 2014. Following this transaction, the President - Marine Systems, In owned 31,194 shares meaning that the stake was reduced by 11.37% with the 4,000-share transaction.

The shares most recently traded at $101.87, up $0.49, or 0.48% since the insider transaction. Historical insider transactions for Kirby go as follows:

  • 4-Week # shares sold: 60,955
  • 12-Week # shares sold: 60,955
  • 24-Week # shares sold: 68,428

The average volume for Kirby has been 371,400 shares per day over the past 30 days. Kirby has a market cap of $5.7 billion and is part of the services sector and transportation industry. Shares are up 3.27% year-to-date as of the close of trading on Monday.

Kirby Corporation, through its subsidiaries, provides marine transportation and diesel engine services primarily in the United States. Its Marine Transportation segment provides transportation services for the inland and coastal markets. The company has a P/E ratio of 22.8. Currently there are 6 analysts that rate Kirby a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEX - FREE

TheStreet Quant Ratings rates Kirby as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Kirby Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cimarex Energy Company (XEC) - FREE Research Report

Box Jerry who is Director at Cimarex Energy Company sold 5,000 shares at $115.51 on Feb. 24, 2014. Following this transaction, the Director owned 12,488 shares meaning that the stake was reduced by 28.59% with the 5,000-share transaction.

Robertson Monroe W who is Director at Cimarex Energy Company sold 3,000 shares at $113.75 on Feb. 24, 2014. Following this transaction, the Director owned 15,037 shares meaning that the stake was reduced by 16.63% with the 3,000-share transaction.

The shares most recently traded at $112.52, down $1.23, or 1.09% since the insider transaction. Historical insider transactions for Cimarex Energy Company go as follows:

  • 4-Week # shares sold: 600
  • 12-Week # shares sold: 19,067
  • 24-Week # shares sold: 33,414

The average volume for Cimarex Energy Company has been 1.0 million shares per day over the past 30 days. Cimarex Energy Company has a market cap of $9.8 billion and is part of the basic materials sector and energy industry. Shares are up 8.71% year-to-date as of the close of trading on Monday.

Cimarex Energy Co. operates as an independent oil and gas exploration and production company primarily in Oklahoma, Texas, New Mexico, and Kansas. As of December 31, 2012, the company owned an interest in 4,953 net productive oil and gas wells. The stock currently has a dividend yield of 0.5%. The company has a P/E ratio of 17.4. Currently there are 13 analysts that rate Cimarex Energy Company a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XEC - FREE

TheStreet Quant Ratings rates Cimarex Energy Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, expanding profit margins, good cash flow from operations and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cimarex Energy Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Perrigo Company (PRGO) - FREE Research Report

Yu Louis who is Executive VP Global Quality at Perrigo Company sold 134 shares at $159.70 on Feb. 24, 2014. Following this transaction, the Executive VP Global Quality owned 5,286 shares meaning that the stake was reduced by 2.47% with the 134-share transaction.

The shares most recently traded at $161.58, up $1.88, or 1.16% since the insider transaction. Historical insider transactions for Perrigo Company go as follows:

  • 4-Week # shares sold: 4,632
  • 12-Week # shares sold: 7,379
  • 24-Week # shares sold: 21,590

The average volume for Perrigo Company has been 1.4 million shares per day over the past 30 days. Perrigo Company has a market cap of $21.3 billion and is part of the health care sector and drugs industry. Shares are up 4.59% year-to-date as of the close of trading on Monday.

Perrigo is buying Canam Care as of Jan 2012 for $36. The stock currently has a dividend yield of 0.26%. The company has a P/E ratio of 32.8. Currently there are 12 analysts that rate Perrigo Company a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRGO - FREE

TheStreet Quant Ratings rates Perrigo Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Perrigo Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

The Worm Has Obviously Turned: Market Recon

The Worm Has Obviously Turned: Market Recon

The Trump Tax Plan Will Make These 15 Stocks Huge Winners: Market Recon

The Trump Tax Plan Will Make These 15 Stocks Huge Winners: Market Recon

Cramer: Can the Pummeled Transports Get Back on Track?

Cramer: Can the Pummeled Transports Get Back on Track?